Latest Breaking News On - Vallon pharmaceuticals - Page 1 : comparemela.com

GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJenene thomasMarc hertzBio operations incAntifibrotic drug development summitCare research respiratory translational collaborationExchange commissionNational institute for healthVallon pharmaceuticals incIreland international lung conferenceAardvark therapeutics incBio incReports third quarterProvides corporateIdiopathic pulmonary fibrosis

Comparing Moleculin Biotech (NASDAQ:MBRX) and Vallon Pharmaceuticals (NASDAQ:VLON)

Comparing Moleculin Biotech (NASDAQ:MBRX) and Vallon Pharmaceuticals (NASDAQ:VLON)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMoleculin biotech incVallon pharmaceuticalsVallon pharmaceuticals incMoleculin biotechGet free reportVallon pharmaceuticalGiven moleculin biotechMoleculin biotech daily

DelveInsight Business Research, LLP: Narcolepsy Market Analysis, Market Size, Epidemiology, and Competitive Analysis of Leading Companies Including Takeda, Suven Life Sciences Limited, Axsome Therapeutics, Inc , Avadel, and Others by DelveInsight

DelveInsight Business Research, LLP: Narcolepsy Market Analysis, Market Size, Epidemiology, and Competitive Analysis of Leading Companies Including Takeda, Suven Life Sciences Limited, Axsome Therapeutics, Inc , Avadel, and Others by DelveInsight
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAthira pharmaPrnewswire delveinsightShruti thakurBioprojet pharmaTherapix biosciencesEli lillyMarket researchPharmaceuticals incVanda pharmaceuticalsCogstate ltdAvadel pharmaceuticalsCentessa pharmaceuticalsJazz pharmaceuticalsSunovion pharmaceuticalsAxsome therapeutics jazz pharmaceuticals

GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc for the Sale of Legacy Asset, ADAIR

GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc for the Sale of Legacy Asset, ADAIR
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomJenene thomasMarc hertzMedice arzneimittelTien leeBio incAardvark therapeutics incVallon pharmaceuticals incCompany or aardvarkExchange commissionAardvark therapeuticsVallon pharmaceuticalsChief executive officerPrader willi syndromePrivate securities litigation reform actAnnual report

GRI Bio Shares Slide to 52-Week Low Amid Sale of Adair Asset >GRI

By Colin Kellaher GRI Bio shares tumbled to a 52-week low on Wednesday after the biotechnology company said it agreed to sell its Adair legacy asset to.

Colin kellaherVallon pharmaceuticalsAardvark therapeuticsArticle normalBiotechnology servicesHealthcare life sciencesFinancial performanceShare price movement disruptionsOwnership changesAcquisitions mergers shareholdingsCorporate actionsCorporate industrial newsContent typesFactiva filtersC amp ampe exclusion filterC amp ampe industry news filter